Vertex Pharmaceuticals, Inc. (VRTX)
436.95
-13.46
(-2.99%)
USD |
NASDAQ |
May 15, 16:00
437.70
+0.75
(+0.17%)
After-Hours: 20:00
Vertex Pharmaceuticals Total Assets (Quarterly) : 26.48B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 92.50B |
| Biogen, Inc. | 29.48B |
| Gilead Sciences, Inc. | 56.28B |
| Regeneron Pharmaceuticals, Inc. | 40.87B |
| Moderna, Inc. | 11.49B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.122B |
| Shareholders Equity (Quarterly) | 19.36B |
| Debt to Equity Ratio | 0.1026 |
| Current Ratio | 3.023 |
| Net Debt Paydown Yield | -0.04% |